Journal
BEHAVIOURAL BRAIN RESEARCH
Volume 352, Issue -, Pages 142-150Publisher
ELSEVIER
DOI: 10.1016/j.bbr.2017.12.014
Keywords
Parkinson's disease; L-DOPA-induced dyskinesia; 6-OHDA; MPTP; Animal models; Rodents
Categories
Funding
- Swedish Parkinson Foundation
- The Greta and Johan Kocks Foundation
- Michael J Fox Foundation
Ask authors/readers for more resources
Animal models of neurological deficits are essential to assess new therapeutic options and reduce treatment complications. Over the last decades, several rodent models of Parkinson's disease have been developed, and have now become the first-line experimental tool for therapeutic screening purposes. Which model is the most predictive for identifying the efficacy of symptomatic or disease-modifying interventions is still a matter of debate. None of the models so far available is able to recapitulate all the features of the human disease, but several well-characterized models with complementary features currently provide a valuable repertoire of tools to address specific scientific hypotheses. This article reviews the rodent models of Parkinson's disease currently available, with a particular focus on symptomatic models used to mimic parkinsonian motor deficits and treatment-related complications. Advantages and disadvantages of each model are presented and discussed to assist the decision of investigators who wonder which model may be the most suitable for their particular research project.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available